. .
Deutsch
Deutschland
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Suchtools
Anmelden

Anmelden mit Facebook:

Registrieren
Passwort vergessen?


Such-Historie
Merkliste
Links zu eurobuch.com

Dieses Buch teilen auf…
..?
Buchtipps
Aktuelles
Tipp von eurobuch.com
FILTER
- 0 Ergebnisse
Kleinster Preis: 106.59 EUR, größter Preis: 198.57 EUR, Mittelwert: 142.42 EUR
Modulation Of Protein Stability In Cancer Therapy
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)

Modulation Of Protein Stability In Cancer Therapy - neues Buch

ISBN: 9780387691435

ID: 5933000

Over the past two decades, there has been a tremendous increase in our understa- ing of ubiquitination and proteasome degradation. As the editors, we thank Springer Publishing for allowing us to organize this collection of reviews on the ubiquit- proteasome system, oncogenesis, and cancer therapy. We asked our colleagues, who are experts in the field, to provide an overview of their research. Over the past two decades, there has been a tremendous increase in our understa- ing of ubiquitination and proteasome degradation. As the editors, we thank Springer Publishing for allowing us to organize this collection of reviews on the ubiquit- proteasome system, oncogenesis, and cancer therapy. We asked our colleagues, who are experts in the field, to provide an overview of their research and recent progress. Each chapter covers a broad range of topics that include defects in ubiquitination identified in specific tumors to new directions to treat cancer. In the Introduction, Rati Verma gives the background of our current understanding of the proteasome. A general overview of ubiquitin ligases and cancer is provided by Angelika Burger and Arun Seth. Patricia McChesney and Gary Kupfer discuss the role of the Fanconi anemia/BRCA1 pathways in breast cancer and potential targets for therapy. Defects in the tumor suppressor, von Hippel-Lindau E3 ligase, and the role of this protein complex are discussed by William Kim and William Kaelin. Kyung-bo Kim and colleagues describe the development of novel proteasome inhibitors to treat cancer patients. Progress in our understanding of deubiquitinating enzymes is summarized by Massimo Loda and his colleagues. Finally, Agustin Rodriguez-Gonzalez and Kathleen Sakamoto discuss an approach to recruit cancer-causing proteins to ub- uitin ligases through a chimeric molecule known as protacs. Books, Medical~~Clinical & Internal Medicine~~Diseases & Disorders, Modulation Of Protein Stability In Cancer Therapy~~Book~~9780387691435, , , , , , , , , ,, [PU: Springer]

Neues Buch Hive.co.uk
MPN: , SKU 5933000 Versandkosten:zzgl. Versandkosten
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Modulation of Protein Stability in Cancer Therapy - Springer
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)

Springer:

Modulation of Protein Stability in Cancer Therapy - neues Buch

ISBN: 9780387691435

ID: 6304eb8a9b0db10d1b662d4c26c7e050

This comprehensive monograph on the role of protein modulation in cancer therapeutics focuses on targeting molecules that regulate protein stability in a variety of tumors. Topics covered include ubiquitin ligases, deubiquitinating enzymes, and the proteasome. Over the past two decades, there has been a tremendous increase in our understa- ing of ubiquitination and proteasome degradation. As the editors, we thank Springer Publishing for allowing us to organize this collection of reviews on the ubiquit- proteasome system, oncogenesis, and cancer therapy. We asked our colleagues, who are experts in the field, to provide an overview of their research and recent progress. Each chapter covers a broad range of topics that include defects in ubiquitination identified in specific tumors to new directions to treat cancer. In the Introduction, Rati Verma gives the background of our current understanding of the proteasome. A general overview of ubiquitin ligases and cancer is provided by Angelika Burger and Arun Seth. Patricia McChesney and Gary Kupfer discuss the role of the Fanconi anemia/BRCA1 pathways in breast cancer and potential targets for therapy. Defects in the tumor suppressor, von Hippel Lindau E3 ligase, and the role of this protein complex are discussed by William Kim and William Kaelin. Kyung-bo Kim and colleagues describe the development of novel proteasome inhibitors to treat cancer patients. Progress in our understanding of deubiquitinating enzymes is summarized by Massimo Loda and his colleagues. Finally, Agustin Rodriguez-Gonzalez and Kathleen Sakamoto discuss an approach to recruit cancer-causing proteins to ub- uitin ligases through a chimeric molecule known as protacs. Bücher / Fremdsprachige Bücher / Englische Bücher 978-0-387-69143-5, Springer

Neues Buch Buch.ch
Nr. 14266515 Versandkosten:Bei Bestellungen innerhalb der Schweiz berechnen wir Fr. 3.50 Portokosten, Bestellungen ab EUR Fr. 75.00 sind frei. Die voraussichtliche Versanddauer liegt bei 1 bis 2 Werktagen., Versandfertig innert 3 - 5 Werktagen, zzgl. Versandkosten
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Modulation of Protein Stability in Cancer Therapy - Springer
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Springer:
Modulation of Protein Stability in Cancer Therapy - neues Buch

ISBN: 9780387691435

ID: 499576917

Over the past two decades, there has been a tremendous increase in our understa- ing of ubiquitination and proteasome degradation. As the editors, we thank Springer Publishing for allowing us to organize this collection of reviews on the ubiquit- proteasome system, oncogenesis, and cancer therapy. We asked our colleagues, who are experts in the field, to provide an overview of their research and recent progress. Each chapter covers a broad range of topics that include defects in ubiquitination identified in specific tumors to new directions to treat cancer. In the Introduction, Rati Verma gives the background of our current understanding of the proteasome. A general overview of ubiquitin ligases and cancer is provided by Angelika Burger and Arun Seth. Patricia McChesney and Gary Kupfer discuss the role of the Fanconi anemia/BRCA1 pathways in breast cancer and potential targets for therapy. Defects in the tumor suppressor, von Hippel Lindau E3 ligase, and the role of this protein complex are discussed by William Kim and William Kaelin. Kyung-bo Kim and colleagues describe the development of novel proteasome inhibitors to treat cancer patients. Progress in our understanding of deubiquitinating enzymes is summarized by Massimo Loda and his colleagues. Finally, Agustin Rodriguez-Gonzalez and Kathleen Sakamoto discuss an approach to recruit cancer-causing proteins to ub- uitin ligases through a chimeric molecule known as protacs. This comprehensive monograph on the role of protein modulation in cancer therapeutics focuses on targeting molecules that regulate protein stability in a variety of tumors. Topics covered include ubiquitin ligases, deubiquitinating enzymes, and the proteasome. Buch (fremdspr.) Bücher>Fremdsprachige Bücher>Englische Bücher, Springer

Neues Buch Thalia.de
No. 14266515 Versandkosten:, Sofort lieferbar, DE (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Modulation of Protein Stability in Cancer Therapy - Kathleen Sakamoto
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Kathleen Sakamoto:
Modulation of Protein Stability in Cancer Therapy - neues Buch

4, ISBN: 9780387691435

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - Over the past two decades, there has been a tremendous increase in our understa- ing of ubiquitination and proteasome degradation. As the editors, we thank Springer Publishing for allowing us to organize this collection of reviews on the ubiquit- proteasome system, oncogenesis, and cancer therapy. We asked our colleagues, who are experts in the field, to provide an overview of their research and recent progress. Each chapter covers a broad range of topics that include defects in ubiquitination identified in specific tumors to new directions to treat cancer. In the Introduction, Rati Verma gives the background of our current understanding of the proteasome. A general overview of ubiquitin ligases and cancer is provided by Angelika Burger and Arun Seth. Patricia McChesney and Gary Kupfer discuss the role of the Fanconi anemia/BRCA1 pathways in breast cancer and potential targets for therapy. Defects in the tumor suppressor, von Hippel-Lindau E3 ligase, and the role of this protein complex are discussed by William Kim and William Kaelin. Kyung-bo Kim and colleagues describe the development of novel proteasome inhibitors to treat cancer patients. Progress in our understanding of deubiquitinating enzymes is summarized by Massimo Loda and his colleagues. Finally, Agustin Rodriguez-Gonzalez and Kathleen Sakamoto discuss an approach to recruit cancer-causing proteins to ub- uitin ligases through a chimeric molecule known as protacs., [SC: 0.00]

Neues Buch Booklooker.de
Carl Hübscher GmbH
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Modulation of Protein Stability in Cancer Therapy - Sakamoto, Kathleen (EDT)/ Rubin, Eric (EDT)
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Sakamoto, Kathleen (EDT)/ Rubin, Eric (EDT):
Modulation of Protein Stability in Cancer Therapy - neues Buch

ISBN: 038769143X

ID: 038769143X

[PU: Springer]

Neues Buch English-Book-Service
Versandkosten:zzgl. Versandkosten
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

< zum Suchergebnis...
Details zum Buch
Modulation of Protein Stability in Cancer Therapy
Autor:

Kathleen Sakamoto

Titel:

Modulation of Protein Stability in Cancer Therapy

ISBN-Nummer:

9780387691435

The book that Sakamoto proposes along with Eric Ruben will be a comprehensive monograph on the role of protein modulation in cancer therapeutics; it will focus on targeting molecules that regulate protein stability in a variety of tumors.

Detailangaben zum Buch - Modulation of Protein Stability in Cancer Therapy


EAN (ISBN-13): 9780387691435
ISBN (ISBN-10): 038769143X
Gebundene Ausgabe
Erscheinungsjahr: 2009
Herausgeber: Springer-Verlag GmbH
165 Seiten
Gewicht: 0,425 kg
Sprache: eng/Englisch

Buch in der Datenbank seit 23.03.2007 07:10:00
Buch zuletzt gefunden am 18.09.2016 21:08:44
ISBN/EAN: 9780387691435

ISBN - alternative Schreibweisen:
0-387-69143-X, 978-0-387-69143-5

< zum Suchergebnis...
< zum Archiv...
Benachbarte Bücher